Purchase Order FA480020P0024
- Not listed
- This is a firm fixed-price purchase order awarded by the Air Combat Command (ACC) to Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company based in Salt Lake City, Utah. The $434,982.96 contract is for the provision of Biofire's FilmArray diagnostic systems, COVID-19 testing reagents, infectious disease testing panels, equipment maintenance services, and cost-per-test diagnostic solutions. The contract does not have a set-aside designation, indicating open competition....
- This contract was awarded by the U.S. Department of the Air Force Air Education and Training Command to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The contract, valued at $160,500.00, is for the provision of COVID-19 testing products and services under a Delivery Order against Biofire's GSA Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has a completion date of...
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company, was issued by the Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base. The $181,500 firm fixed-price purchase order is for supplies related to COVID-19 testing. The contract has no set-aside designation, indicating open competition. Biofire Diagnostics is an experienced federal contractor, holding several Indefinite Delivery Vehicles (IDVs) and Blanket...
- The U.S. Air Force's Air Mobility Command awarded Biofire Defense LLC a $278,480 firm fixed-price delivery order on March 18, 2020, to provide COVID-19 Film Array network kits and instruments for McGuire Air Force Base in New Jersey. This delivery order, issued under a Multiple Award Schedule contract vehicle, supported the federal government's urgent response to the coronavirus pandemic and leveraged Biofire Defense's core molecular diagnostic capabilities. The award carried no set-aside...
- The Department of the Air Force awarded a definitive contract valued at $33.1 million to Biofire Defense LLC of Salt Lake City, Utah. The firm fixed price contract is to provide "COVID 19" BIOFIRE RESPIRATORY 2.1 (RP2.1) PANEL WITH SARS_COV-2 diagnostic testing kits compatible for use on BioFire 2.0, BioFire Torch, and other BioFire analyzers. The solicitation sought proposals to supply these BioFire Respiratory 2.1 panels to detect SARS-CoV-2 and 21 additional respiratory pathogens...
- This is a firm fixed-price purchase order awarded by the Department of the Air Force Air Combat Command to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for COVID-19 BIOFIRE FILMARRAY TORCH MODULES. The potential value of the contract is $112,000.00. The contract is not designated as a set-aside. Biofire Diagnostics LLC is a biotech company that specializes in syndromic infectious disease testing and has received numerous federal contract awards as a prime contractor to...
- This federal contract award is for a BIOFIRE LAB TESTING UNIT, with a Firm Fixed Price of $125,500.00, awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to the prime contractor Biofire Diagnostics LLC. The contract is in support of the Coronavirus COVID-19 national interest action and was awarded on April 17, 2020 with a completion date of June 30, 2020. Biofire Diagnostics LLC is a for-profit, foreign-owned biotech company that specializes in syndromic...
- This federal contract award was made by the Air Force Materiel Command to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $285,921.23 firm fixed price delivery order is for in vitro diagnostic substances, reagents, test kits, and sets, and was issued against Biofire's General Services Administration Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The award has no set-aside designation. Biofire Diagnostics has...
- This federal contract award was made by the Air Force Materiel Command to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $334,258.73 firm fixed-price delivery order was placed against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The contract provides in vitro diagnostic substances, reagents, test kits, and sets to the Air Force. No set-aside designation was...
- This federal contract award is for BIOFIRE FILM ARRAY REAGENT KITS provided by Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company based in Salt Lake City, Utah. The $2,335,229.38 firm fixed price delivery order was awarded on April 3, 2020 to the prime contractor, with an ultimate completion date of April 2, 2025. The funding agency is the Veterans Integrated Service Network 17, a civilian healthcare network within the Department of Veterans Affairs. Biofire Diagnostics...
The U.S. Air Force's Air Combat Command awarded a $112,000 firm fixed-price purchase order to Biofire Diagnostics LLC on April 2, 2020, for COVID-19 tests to support operations at Langley Air Force Base in Virginia. The contract, which represents an urgent procurement response to the coronavirus pandemic, was completed by April 17, 2020. This award was issued without a set-aside designation, reflecting Biofire Diagnostics' competitive standing in the federal marketplace. The contract likely leverages the vendor's existing General Services Administration Federal Supply Schedule contract for in-vitro diagnostics and testing solutions. Biofire Diagnostics LLC, a Salt Lake City-based biotechnology company specializing in advanced molecular diagnostic testing, has established itself as a key supplier of diagnostic products to federal healthcare agencies, particularly the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency. The company's diagnostic portfolio includes its proprietary FilmArray systems and molecular pathogen detection panels capable of rapidly identifying multiple infectious disease pathogens. This COVID-19 testing award represents one component of the company's broader federal contract strategy, which encompasses multiple blanket purchase agreements and indefinite delivery vehicles valued collectively in the millions of dollars across various federal healthcare systems with performance periods extending through 2027.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
COVID-19 Testing Kits | FA4800-20-P-0024 | Department of the Air Force Air Combat Command | Limited / Sole Source Justification 1/1 | 4/2/20, 4:28 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $112.0k | 4/2/20 |